XBiotech Says CHMP ‘No’ Was A Surprise, Despite The Signs

Where now for XBiotech? The US firm says that despite a big setback for Xilonix in the EU, it will continue to develop the product in oncology.

Hand pick and pull paper or curtain from bad cloudy sky to be clear bright blue sky and white cloud
XBiotech is optimistic about Xilonix despite setback in the EU • Source: Shutterstock

More from Approvals

More from Product Reviews